Continuous Distillation for Drug Substance Manufacturing
Pharmaceutical Research · 2026
DOI: 10.1007/s11095-026-04172-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Research, 2026. Verfasst von Kimberly E Penzer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Life Science Engineering, Virginia Commonwealth University, 601 West Main St., Richmond, VA, 23284, USA. Hauptthemen laut MEDLINE: Distillation, Technology, Pharmaceutical. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Defense Sciences Office, DARPA, U.S. Food and Drug Administration.
Abstract (Originalsprache)
Purpose
Continuous distillation is widely used in the commodity and petrochemical industry to purify fine chemicals on massive industrial scales; however, this key separation strategy is largely unused within the pharmaceutical industry. This article investigates the development of a pilot-scale continuous distillation system for in-line removal of an excess amine reactant ( i.e. , tert-butylamine) when incorporated within an advanced manufacturing technology (AMT) for continuous drug substance production.
Methods
Initial design parameters were simulated in ASPEN + to assess potential process solvents, setpoint parameters, and azeotrope formation. Complementary analytical characterization was performed with high performance liquid chromatography (HPLC) and gas chromatography – flame ionization detection (GC-FID). Early continuous distillation prototypes and key engineering design decisions are highlighted.
Results
The final engineered system is comprised of a + 3-foot distillation column fitted with an Allihn condenser, a 250 mL three-necked round bottom flask, and an automated system for reflux ratio (R D ) control. The column is readily integrated within an advanced manufacturing system to continuously remove amine reagent during continuous manufacturing of albuterol sulfate at a 3.0 mL/min process basis, corresponding to a theoretical throughput of approximately 1,800 doses per hour based on the demonstrated process flowrate, reaction stoichiometry, and operating conditions.
Conclusions
The application of continuous distillation offers a unique strategy for impurity removal during advanced pharmaceutical manufacturing and can be scaled to meet target throughputs. Here we provide general criteria necessary for successful implementation of similar continuous in-line distillation systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Life Science Engineering, Virginia Commonwealth University, 601 West Main St., Richmond, VA, 23284, USA.
- Department of Chemical and Life Science Engineering, Virginia Commonwealth University, 601 West Main St., Richmond, VA, 23284, USA. jkferri@vcu.edu.
Förderung
- Defense Sciences Office, DARPA
- U.S. Food and Drug Administration
Zitieren
APA
Penzer, K. E., Gregory, D. G., Turnage, J. T., Thieken, C. D., Kohn, S. G., & Ferri, J. K. (2026). Continuous Distillation for Drug Substance Manufacturing. Pharmaceutical Research. https://doi.org/10.1007/s11095-026-04172-7
Vancouver
Penzer KE, Gregory DG, Turnage JT, Thieken CD, Kohn SG, Ferri JK. Continuous Distillation for Drug Substance Manufacturing. Pharmaceutical Research. 2026. doi:10.1007/s11095-026-04172-7
BibTeX
@article{Penzer2026,
author = {Penzer, Kimberly E and Gregory, Daniel G and Turnage, Justin T and Thieken, Colin D and Kohn, Samantha G and Ferri, James K},
title = {Continuous Distillation for Drug Substance Manufacturing},
journal = {Pharmaceutical Research},
year = {2026},
doi = {10.1007/s11095-026-04172-7}
}
EUVIMED